Annie Sabbah

Paragate Medical Ltd. engages in the development of implantable device for the treatment of fluid overload in patients suffering from chronic heart or kidney failure. The company was founded by Nitai Hanani and Yair Feld in 2016 and is headquartered in Haifa, Israel.

Nervomatrix Ltd. develops non-invasive drug-free pain relief products for the pain clinicians' market. It offers Auto-Targeting Neurostimulation, a back-pain relief solution that allows pain clinicians to treat only the specific area identified to be effective for pain relief. The company was founded by Miguel Gorenberg in 2007 and is headquartered in Kfar Haroeh, Israel.

Technion Seed Ltd. (Technion Seed) is an independent Israeli seed-stage investment firm which was established in 1991 as the Technion Incubator. The firm is headquartered in Haifa, Israel.

ParaSonic Ltd. engages in the development of a device for lice infestations. It offers CARELY a home-use device that kills lice and their eggs in a single combing treatment. The company was founded by Mor Cohen and is headquartered in Tel Aviv, Israel.

NGT New Generation Technologies Ltd (NGT3) is a venture capital firm founded in 2002 by Nasri Said and Kayid Abu Ayash. The firm is headquartered in Nazareth Eli, Israel.

Aqueduct Medical Ltd. develops a technology for use in dilating the uterine cervix and various other body cavities. The company was founded by Omer Harpaz and is headquartered in Nazareth Elit, Israel.

Eio Biomedical Ltd. operates as a biotechnology company developing a medical device for the prevention of post-surgical adhesions. The company was founded in 2006 and is headquartered in Nazareth, Israel.

Nurami Medical Ltd. develops surgical scaffold platform for the repair, regeneration and healing of soft tissues following internal surgeries. Its product pipeline include Artifascia and Artifix. The company was founded by Amir Bahar and Nora Nseir in 2014 and is headquartered in Haifa, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

Implant B Ltd. engages in the development of a multi piece dental implant for treating peri-implantitis while preserving the implant and the dental restoration. The company was founded by Liat Chaushu on July 21, 2014 and is headquartered in Nazareth, Israel.

Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel.

OTTek Ltd. is an Israeli medical device company that specializes in state-of-the-art innovative practical GI endoscopy solutions. The company is based in Nazareth, Israel. The company has developed the FIoT (Flow in Over Tube), a versatile, on-demand, easy-to-assemble, cost-effective colonoscopy assist device. The company was founded in 2018, and the CEOs are Yoav Lichtenstein and Zohar Gendler.

Intragel Therapeutics Ltd. is an Israeli science-based company that develops an innovative, state-of-the-art treatment for solid tumors based on an intra-tumoral injectable delivery system with extended release of anticancer drugs. The company is based in Nazareth, Israel. The company's technology can be applied to a wide range of anti-cancer drugs and is suitable for various types of solid tumors. Intragel's formula is loaded into a ready-to-use pre-filled syringe, which is applied directly into the tumors. The drug is slowly released, shrinking the tumor without side effects. Intragel was founded by Peter Siman, Avi Domb, and Avner Geva, and Peter Siman has been the CEO since incorporation.

Ark Surgical Ltd. is an Israeli medical device company that specializes in the commercialization of the LapBox tissue containment removal system. The company is based in Israel and was founded by Abraham Yaari, Aaron Feldman. The LapBox is a safe and minimally-invasive alternative for gynecologists using laparoscopic surgery. The company was founded by medical device veterans with hands-on experience in the clinical setting and operates as a portfolio company of the NGT³ venture capital fund. The CEO is Stav Tori.

Nina Medical Ltd. specializes in ultrasound imaging of the prostate and pelvic floor, as well as non-invasive, focal therapy of the prostate using high-intensity focused-ultrasound (HIFU). The company is based in Nazareth, Israel. The Israeli company is a pioneer in ultrasound imaging of HIFU, where the therapeutic field is captured and displayed by the diagnostic field. Nina Medical introduces the concept of the therapeutic pillow, a membrane-covered integrated applicator for diagnostic and therapeutic ultrasound, which delivers HIFU energy to the prostate while providing treatment planning, guidance, and control. Shmuel Ben-Ezra has been the CEO of the company since 2019.

A.R Guide In Medical Ltd. operates as a medical device company engaging in the development of non-invasive guided intubation device. The company was founded by Ariel Shrem, Elchanan Fried, and Itai Hayut in 2015 and is headquartered in Nazareth, Israel.

Tendomend Ltd. is developing an invasive implant and a corresponding deployment system to replace the current suturing approach in tendon repair. The company was founded by Valavanis Ioannis and Almon Ehud on February 17, 2019 and is headquartered in Nazareth, Israel.

Plas-Free Ltd. develops revolutionizing massive bleeding treatment medical devices. The company was founded by Abd Al-Roof Hijazi and is headquartered in Nazareth, Israel.

Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT.

D Pharm Ltd. provides drug development services.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.

CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel.

DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.

BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium.

VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.